Valiant Organics Limited

Valiant Organics Limited

429.65
INR
+1.25
(+0.29%)
19.40EPS
13.88P/E
7.52BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
58.39
81.09
71.56
62.57
102.86
284.92
277.77
294.34
424.72
387.36
264.93
260.46
263.75
273.67
Basic EPS, GAAP
7.61
9.99
14.07
9.91
13.93
54.83
51
44.68
41.72
32.45
-3.07
-1.35
11.87
19.33
Free Cash Flow per Basic Share
0.37
6.36
21.98
4.67
9.69
-5.36
-18.05
-21.94
-56.5
31.75
3.32
9.28
20.87
- -
Dividend per Share
2.46
6
12.04
3.01
3.91
4.31
10.85
2.65
- -
4.5
- -
- -
- -
- -
Book Value per Share
25.6
29.4
31.25
65.14
50.46
247.06
158.75
184.83
225.66
253.66
264.48
258.98
271.02
- -
Tangible Book Value per Share
25.6
29.4
31.25
65.14
50.46
241.43
157.58
180.28
221.12
249.04
259.92
254.42
266.49
- -
Basic Weighted Avg Shares
7
7
7
12
12
24
24
26
27
27
27
28
28
28
Sales/Revenue/Turnover
425
590
521
734
1,206
6,923
6,749
7,548
11,533
10,518
7,231
7,188
7,388
7,659
Operating Margin (%)
33.43
32.05
29.24
23.15
20.42
24.43
24.46
24.79
15.54
13.13
0.44
2.61
6.79
8.42
Depreciation Expense
8
8
9
17
22
136
154
212
296
292
349
358
396
404
Net Income, GAAP
55
73
102
116
163
1,332
1,239
1,146
1,133
881
-84
-37
332
541
Effective Tax Rate (%)
32.41
33.5
34.85
35.11
35.26
29.18
25.1
29.21
27.39
25.23
- -
259.31
20.76
19.7
Profit Margin (%)
13.04
12.32
19.66
15.83
13.54
19.25
18.36
15.18
9.82
8.38
-1.16
-0.52
4.5
7.06
Working Capital
73
94
96
169
256
989
549
326
1,176
783
11
-128
20
- -
LT Debt
- -
- -
- -
3
3
449
841
753
1,063
717
745
508
553
- -
Total Equity
186
214
228
474
592
3,014
4,007
5,086
6,489
7,401
7,293
7,253
7,594
- -
Return on Invested Capital (%)
27.12
27.56
39.21
27.88
29.59
54.29
26.96
21.01
15.08
10.58
- -
-3.06
4.46
- -
Return on Capital (%)
29.07
29.11
39.44
32.5
30.44
61.89
26.88
16.2
11.95
8.07
- -
-4.32
4.79
- -
Return on Common Equity (%)
33.05
36.32
46.4
33.11
30.65
76.37
36.69
25.81
20.33
13.54
-1.18
-0.51
4.48
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
2,006
- -
LT Borrowings
- -
526
- -
LT Finance Leases
- -
26
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
28
28
28
Market Capitalization
7,684
5,674
7,519

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
3,522
- -
Cash, Cash Equivalents & STI
- -
57
- -
Accounts Receivable, Net
- -
2,433
- -
Inventories
- -
915
- -
Total Current Liabilities
- -
3,503
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
2,006
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
64.67%
8.87%
4.7%
Free Cash Flow
33.02%
47.55%
128.32%
Net Income, GAAP
-42.29%
-235.58%
-989.56%
Sales/Revenue/Turnover
60.33%
2.98%
2.78%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1,679
1,602
1,869
2,038
7,188
2026
2,044
1,573
1,593
2,178
7,388
2027
2,315
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.23
-4.52
1.98
1.52
-1.35
2026
2.93
2.02
1.3
5.61
11.87
2027
10.44
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Sathiababu Krishnan Kallada
Full Time Employees
908
Sector
Process industries
Industry
Chemicals: specialty
Address
Tower-B, Embassy 247 Mumbai MA India 400083
IPO Date
Oct 14, 2016
Business
Valiant Organics Limited (VALIANTORG.NS) manufactures and supplies specialty chemicals for the agrochemicals, pharmaceuticals, engineering plastics, polymer additives and specialty pigments industries. The company produces a range of products including ortho amino phenols such as ortho phenylene diamine (OPD), 4 amino 2 nitro phenol, 2 amino 4 nitro phenol, 2 amino 5 nitro phenol and 2 amino 4 chlorophenol; meta amino phenols such as meta phenylene diamine (MPD), 3 amino 4 hydroxy toluene and 2 amino 4 hydroxy toluene; para amino phenols such as para nitro aniline, para amino phenol and para amino phenol salts; nitrochlorobenzenes such as ortho nitro chlorobenzene and para nitro chlorobenzene; and other chemicals including nitro aniline derivatives and hydrazine hydrate; as well as pharmaceutical intermediates and performance chemicals. Valiant Organics operates manufacturing facilities in Ambernath and Kurkumbh in Maharashtra, India, and exports to markets in Europe, the United States and Asia. Founded in 2005 and headquartered in Mumbai, India, the company is promoted by the Manjrekar family. In fiscal 2025, Valiant Organics reported revenue growth driven by increased volumes in OPD and new product launches in pharmaceutical intermediates, alongside capacity expansions at its Kurkumbh facility to support agrochemical demand; the company also formed strategic supply alliances with global agrochemical majors and completed a debt refinancing to bolster working capital for export growth.